-
-
David M. Solomon, RN, BSN, CEN, EMT-P, patient care coordinator in the ED at Catawba Valley Medical Center in Hickory, NC, says that usually, medications for boarded patients have to be ordered from the pharmacy.
-
When Craig Thiele, MD, chief medical officer of Dayton, OH-based CareSource, the state's largest Medicaid managed care plan, thinks of 2014, he remembers the need to "be sure, from the sheer aspect of supply and demand, that we don't get into trouble."
-
Efforts to eliminate the individual mandate requiring individuals to purchase health care insurance, included in the Patient Protection and Affordable Care Act (PPACA), "have a probability of success," according to Leslie Hendrickson, PhD, principal of Hendrickson Development, an East Windsor, NJ-based consulting group which helps to develop and strengthen long-term care programs.
-
Minnesota faces a projected state budget deficit of $5 billion for the next biennium and increased program enrollment and health care costs in Medical Assistance, Minnesota's Medicaid program, reports David Godfrey, Minnesota state Medicaid director.
-
If a state doesn't institute the Medicaid expansion included in the Patient Protection and Affordable Care Act (PPACA), that state would no longer be eligible for federal Medicaid funds, just as it would not be eligible if it didn't cover children up to the current mandatory levels, says Edwin Park, vice president for health policy at the Center on Budget and Policy Priorities in Washington, DC.
-
In this issue: Calcium supplements and MI; birth control pills and VTE; ACE inhibitors and breast cancer risk; spending on pharmaceuticals; and FDA actions.
-
Although the annual incidence of all gynecological malignancies remains between 75,000 and 80,000, a far greater number of women with this history are survivors.
-
This publication is an update on osteoporosis screening from the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation.
-
Over the years, different tocolytics have been in vogue, only to be discarded later because meta-analyses showed that the agent simply did not work. This month's review will focus on nifedipine, a medication that has been in and out of favor for more than 20 years.